Abstract
]o). The mesangial cells are known to be involved in many pathologic sequences through the mediation of altered glomerular hemodynamics, cell proliferation, and matrix production. In this study, we examined the expression of the CaSR in the mouse mesangial cell lines (MMC, ATCC number CRL-1927). Reverse transcription-polymerase chain reaction (RT-PCR) was perform with CaSR-specific primers, and this was followed by nucleotide sequencing of the amplified product; this process identified the CaSR transcript in the MMCs. Moreover, CaSR protein was present in the MMCs as assessed by Western blot and immunocytochemical analysis using a polyclonal antibody specific for the CaSR. 
Introduction
Serum calcium levels in healthy adults remain stable because the amount of calcium entering the extracellular compartment matches the amount excreted by the kidneys. This balance is mainly achieved by the calcium-sensing receptor (CaSR) that is located on the surface of the various types of cells (Houillier et al., 2003) . In addition, extracellular calcium is essential for a number of vital processes, including bone mineralization, blood coagulation, regulation of enzymatic activity and the modulation of the permeability and excitability of the plasma membranes. For these reasons, the calcium concentration in the extracellular fluids is under strict control by a complex homeostatic system that includes the bones, kidney, intestines and the parathyroid and thyroid glands (Brown, 1991; Shin et al., 2003 , Jung et al., 2005 . The extracellular CaSR is an essential component of this system for regulating the parathyroid hormone secretion and the Ca 2+ excretion by the kidney. The CaSR belongs to the type III family of G-proteincoupled receptors that comprises the metabotropic glutamate receptor and the putative vomeronasal organ receptors (Brown et al., 1993) .
In the kidney, experimental studies have suggested that CaSRs increase the intracellular calcium concentration and they regulate divalent mineral reabsorption, water reabsorption and urinary concentration (Riccardi et al., 1996 , Arthur et al., 1997 .
The extracellular calcium sensing receptor is expressed in mouse mesangial cells and modulates cell proliferation
These studies have also shown the distribution of CaSRs along the rat nephron. They showed the existence of the CaSR transcript using RT-PCR and the in situ hybridization technique. The CaSRs are localized at the glomeruli, the proximal convoluted tubule, the proximal straight tubule, the cortical thick ascending limb, the distal convoluted tubule and the cortical collecting duct (Brown et al., 1993; Riccardi et al., 1996; Caride et al., 1998) . Although the physiological roles of CaSRs in the proximal convoluted tubule, the proximal straight tubule, the cortical thick ascending limb, the distal convoluted tubule and the cortical collecting duct are relatively well established (Riccardi et al., 1996; Desfleurs et al., 1998; Faurskov and Bjerregaard, 2002; Conigrave and Lok, 2004) , the investigations on the signal transduction cascade and the physiological function of CaSR in the glomerulus have not been conducted. The glomerulus is an important component of the nephron because renal filtration starts from this portion. The glomerulus is composed of several types of cells such as the endothelial cells, the mesangial cells, the epithelial cells and the podocytes. Among them, the mesangial cells play an important role for the regulation of glomerular filtration by contraction, for the secretion of structural elements and for the endocytosis of macromolecules including immune complexes (Mene et al., 1989) . Therefore, understanding the functional role of the CaSRs in mesangial cells gives scientists additional information on the renal physiology of CaSRs. The purpose of our current study is to clarify the expression and the physiological function of CaSRs by using molecular techniques and cell proliferation assay on the glomerular mesangial cell line.
Materials and Methods

Materials
The agents used in this study were purchased from the following sources: NPS 2390, Fura-2/ AM and TRI reagent from Sigma Chemical (St. Louis, Mo.); Dulbecco's modified Eagles Medium (DMEM), calcium free DMEM, penicillin-streptomycin and fetal bovine serum (FBS) from Gibco BRL (Grand Island, NY); ATP monitoring reagent from Bio Orbit, Turku, Finland; Reverse transcription-polymerase chain reaction related materials from TaKaRa Korea (Seoul, Korea); Polyclonal CaSR antibody from Affinity BioReagents (Deerfield, IL) and secondary antibodies from Jackson Immunoresearch (West Grove, PA). All other chemicals used were of the highest grade available.
Cell culture
The mouse mesangial cell line (MMC, CRL1927) was purchased from American Type Culture Collection and cultured in high glucose DMEM supplemented 10% heat-inactivated FBS, penicillin (100 U/ml) and streptomycin (100 U/ml). Cultures were maintained at 37 o C in a 5% CO 2 humidified air. (Cha et al., 2004) . The primer sequences for CaSR were designed within coding region (sense 5'-TCA ACC TGC AGT TCC TGC TGG-3' and antisense 5'-TGG CAT AGG CTG GAA TGA AGG-3'; product size 318 bp).
Total RNA isolation and RT-PCR analysis
Western blot analysis
The MMCs were washed with cold phosphatebuffered saline (PBS, pH 7.4) and harvested. Subsequently, the cells were homogenized in 9 volumes of 0.3 M sucrose, 0.26 U/ml aprotinin, 0.1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml trypsin inhibitor, with 10 strokes of a motordriven Teflon/glass homogenizer. The homogenate was centrifuged for 5 min at 500 × g, and the supernatant was centrifuged further for 10 min at 8,000 × g. The supernatant was centrifuged for 40 min at 100,000 × g, and the membrane pellet was resuspended in 0.25 M sucrose, 100 mM KCl, 5 mM MgCl2, and 50 mM Tris (pH 7.4). The protein samples were heated at 100 o C for 10 min in sample buffer and subjected to 10% SDS-polyacrylamide gel electrophoresis. The separated proteins were transferred electrically to a Hybond-P polyvinylidene difluoride transfer membrane (Amersham Pharmacia Biotech). This membrane was blocked with solution of 5% non-fat dried milk. Membrane was then incubated with CaSR antibody (1:200) for 1 h at room temperature and then incubated further with the horseradish peroxidase-conjugated secondary antibody (1:3000) for another 1 h at room temperature. After washing, the membrane was visualized by the ECL kit (Amersham Pharmacia Biotech. Buckinghamshire, UK).
Confocal microscopy
The cultured MMCs on cover slips were fixed with 95% ice-cold ethanol for 10 min at room temperature and permeabilized by 0.1% Triton X-100 solution in PBS (10 min in room temperature). The nonspecific binding sites were blocked with 10% goat serum in PBS for 30 min in room temperature. Polyclonal CaSR antibody (1:100) was treated to the fixed cells for 1 h in room temperature. Secondary antibodies without prior antibody treatment were also included as controls. After washing, cells were stained with fluorescein isothiocyanate (FITC)-conjugated secondary antibodies for 30 min. After washing, samples were examined appropriate-wavelength under a Bio-Rad MRC 1000 confocal microscope. More than 50 cells have been inspected per experiment and the photos of cells with typical morphology and staining are presented.
Measurement of [Ca
2+
] i [Ca 2+ ]i was measured using the method previously described (Jung et al., 2005) . Cells were harvested and seeded on to a 22 × 22 cover glass attached to a 1-cm 2 area at the bottom of 35-mm plastic culture dishes at a concentration of 10 4 cells/dish on the two days before conducting the experiment. Cells were then washed with modified Hanks' solution consisting of (in mM): NaCl, 127; MgSO4, 0.8; KH2PO4, 0.44; NaHPO4, 0.33; MgCl2, 1; HEPES, 10; CaCl2, 0.5; pH 7.4; they were then loaded in Fura-2/AM (10 M) for 30 min at 37 o C. Fluorescence-loaded cells were washed three times with the same solution to exclude the unloaded Fura-2/AM. The fluorescence in MMCs was measured at room temperature using the InCa TM Imaging System (Intracellular Imaging Inc., Cincinnati, OH). The [Ca 2+ ]i was calculated from a standard curve generated in situ.
Measurement of IP 3
IP3 contents by extracellular calcium in MMC were determined using a radioimmunoassay kit (Amersham, UK). In brief, the MMCs in 0.5 mM calcium and serum free DMEM were preincubated with 10 mM LiCl at 37 o C for 10 min. To analyze the IP3 production, the MMCs were incubated at 37 o C for 20 s following their addition to the chemicals (CaCl2, U73122 and CaSR antagonist). The reaction was terminated by the addition of 100% trichloroacetic acid (final concentration; 15% wt/vol). After collecting the supernatant, pH was adjusted to 7.50 by titration. The aqueous layer was separated by centrifugation (3,000 × g) for 15 min at 4 o C. An aliquot (100 l) of supernatant was transferred to a scintillation vial (polypropylene, 12 × 75 mm) for quantitation of the IP3. The IP3 contents in the supernatant were determined using a radioimmunoassay kit (Amersham, UK) (Jung and Endou, 1990) . Samples were normalized based on total protein using a BCA protein assay.
Determination of cell proliferation
Cells were seeded at a concentration of 5 × 10 3 cells/well to a 12-well plate and incubated for 1 day for cell attachment to the bottom. After confirmation of cell attachment, extracellular calcium varying concentrations (1, 5 and 10 mM) and with/without CaSR antagonist (NPS 2390, 5 M) were treated for 7 days. To determine cell proliferation, cells were detached using trypsin-EDTA solution (0.25%) and the cell number was counted using trypan blue staining .
Determination of intracellular ATP content
Intracellular ATP was measured with a microchemiluminescence method. After removing the supernatant, 1 ml of 10% trichloroacetic acid was treated for extraction of cellular ATP. Then, 10 l of the extracted samples were transferred to polystyrene cuvettes filled with 160 l of 0.1 M tris (hydroxymethyl)aminomethane/acetate buffer containing 0.5 mM EDTA (pH 7.75). The cuvettes were set into a luminometer (TD-2020, Turner Designs, CA). After the addition of ATP-monitoring agent (40 l), the light intensity was measured.
Statistical analysis
Data obtained were expressed as the means ± SE. Statistical analysis was performed using Student's t test and ANOVA for two-group comparison and the comparison of multiple data, respectively. A P value less than 0.05 is considered statistically significant.
Results
Expression of CaSR mRNA and protein in MMCs
In order to confirm the molecular appearance of CaSR mRNA and protein, RT-PCR and Western blot analysis were performed on the MMCs. As shown in Figure 1A , the designated PCR product (318 bp) was observed ( Figure 1A ). The identities of the PCR products were confirmed by nucleotide sequencing after they were subcloned into a TA-cloning vector (Invitrogen, data not shown). The CaSR protein (about 120 kDa) was also detected in the MMCs ( Figure 1B) . When the CaSR protein expression was confirmed by immunocytochemistry, the CaSR pro-tein was localized at the plasma membrane along with some cytoplasmic localization ( Figure 1C ). As shown in Figure 1D , any effect of the secondary antibody was not detected. ] i , as measured in the bathing solution that contained 0.5 mM CaCl 2 , was 57 ± 6 nM (n = 60). As shown in Figure 2, ] o -induced IP 3 production. When the extracellular calcium (10 mM for 20 s) was treated to MMCs, IP 3 accumulation was 2.6 ± 0.4 times of basal levels (n = 3, P ＜ 0.05). As shown in Figure 3E , this extracellular calcium-stimulated IP 3 elevation was significantly inhibited by the pretreatment with U73122 (1 M for 20 min; 1.3 ± 0.2 times of basal level) and NPS 2390 (10 M for 2 min, 1.1 ± 0.4 times of basal level). The single effect of U73122 and NPS 2390 was negligible (data not shown). 
Effects of extracellular
Effects of extracellular calcium on MMC proliferation
To investigate the physiological role of CaSR, the effect of [Ca 2+ ] o on the cell proliferation was studied. Elevating the [Ca 2+ ] o from 1 to 5 mM was sufficient to elicit proliferation after a chronic treatment of at least 5 days. The percent increments of the cell proliferation were 16.7% and 37.5%, as compared with the control ([Ca 2+ ] o = 1 mM) at 5 days and 7 days, respectively ( Figure 4A ). This increment by [Ca 2+ ] o was significantly inhibited by the co-treatment with the antagonist of CaSR (NPS 2390, 5 M). There was no single effect for NPS 2390. This increment of cell proliferation was also confirmed by determining the cellular contents of ATP ( Figure 4B ). The high concentration of [Ca 2+ ] o (10 mM) did not affect cell viability ( Figure 4B ).
Discussion
The results obtained in the current study demonstrate for the first time that the extracellular calcium sensing receptor (CaSR) is expressed in the renal glomerular mesangial cells, and CaSRs play an important role in cell proliferation. Several lines of evidences that are provided in the present study support this conclusion. Extracellular calcium is essential to a number of processes throughout the body, including blood coagulation, bone mineralization, enzymatic regulation and control of the permeability and excitability of the plasma membranes. The levels of serum calcium remain stable in healthy adults because the amount of calcium entering the extracellular compartment matches the amount excreted through the kidneys. The narrow range of the extracellular calcium concentration is largely regulated by parathyroid hormone (PTH). In addition, the calcium sensing receptor (CaSR) also contributes to the regulation of the serum calcium concentration (Drueke, 2004) .
Hypercalcemia has been shown to occur in primary hyperparathyroidism, malignancy and less frequently, in hypervitaminosis D or sarcoidosis (Wrong, 1998) , and renal injury is often seen with hypercalcemia. In the kidney, hypercalcemia can alter many aspect of renal function, including reducing the glomerular filtration rate (Porter et al., 1999) and increasing renal vasoconstriction (Fynn et al., 1977) . There have been a numerous reports on the roles of the CaSRs in the kidney. Riccardi and coworkers (Riccardi et al., 1996) have shown the localization of CaSRs along the rat nephron. This result well agrees with the reported physiological roles for CaSRs in the nephron segments. They also showed that CaSRs are localized in the glomerulus. Unfortunately, there have been no reports on the roles of CaSRs in the glomerulus. Therefore, we investigated the role of CaSRs in the mesangial cells. Mesangial cells respond to a variety of vasoactive agents such as angiotensin II, vasopressin, leukotrienes, platelet activating factor and so forth (Ausiello et al., 1980; Kreisberg et al., 1985; Schlondorff, 1987) . The mesangial cells are also known to be involved in many pathologic sequences through the mediation of altered glomerular hemodynamics, cell proliferation, and matrix production (Mauer, 1994; .
In the first step of our current study, we performed RT-PCR, Western blot analysis and immunocytochemistry for confirmation of the CaSR expression in the cultured mouse mesangial cell lines (MMC). The result of this experiment well demonstrated the expression of CaSRs. The major portion of the CaSR protein was localized in the plasma membrane with the cytoplasmic expression in the MMC (Figure 1 ). The glomerulus is composed of several cell types such as endothelial cells outlining the glomerular capillaries, mesangial cells functioning as pericytes adjacent to the glomerular capillary, and visceral glomerular epithelial cells or podocytes attached to the glomerular epithelial cells covering the inner surface of the Bowman's capsule (Remuzzi and Bertani, 1998) , and so additional experiments that will demonstrate the existence of CaSRs in other glomerular endothelial and epithelial cells will be necessary. In order to characterize the signaling mechanism of the CaSRs, the extracellular Ca 2+ ([Ca 2+ ]o) induced intracellular free calcium ([Ca 2+ ]i) mobilization was studied. Henegar et al. (Henegar et al., 2003) reported the two cases of glomerular calcification in hypercalcemic nephropathy. In these patients serum calcium concentrations were 4.6 mM and 5.0 mM, respectively. In other case, dramatic millimorar el- 3 cells/well to a 12-well plate and incubated for 1 day for cell attachment to the bottom. Cells were counted after detaching using trypsin-EDTA. *P ＜ 0.05, **P ＜ 0.01 versus control and ## P ＜ 0.01 versus 5 mM [Ca 2+ ]o group. (B) Quantitative evaluation was performed at the 7 day using measurement of intracellular ATP contents as described in Materials and Methods. All wells, in triplicate, were solubilized with 1% trichloroacetic acid and the ATP content was determined. The results are represented as means ± SE in triplicate from 3 different experiments.
evations of extracellular calcium (as much as 40 mM) are generated near the resorption sites as osteoclasts dissolve the mineralized matrix (Silver et al., 1988) . Therefore, typical response pattern to [Ca 2+ ]o and concentration dependency were investigated at 10 mM and up to 20 mM of [Ca 2+ ]o. The CaSR mediated [Ca 2+ ]i increase was biphasic, and it was composed of an initial rapid increase and then a sustained increase. The high concentration of the extracellular Ca 2+ increased the [Ca 2+ ]i in a dosedependent manner. In the current experiment, the half-maximal effective concentration of [Ca 2+ ]o necessary to achieve the [Ca 2+ ]i responses in the MMCs was about 7.2 mM (Figure 2 ). This value showed to be slightly higher than the previously reported values. Bai et al. (Bai et al.,1998) and Godwin (Godwin and Soltoff, 2002 ) demonstrated values of 4.0 mM in the CaSR transfected kidney cells and 4.6 mM in the MC3T3-E1 osteoblasts, respectively.
To further characterize the signaling mechanism of the CaSRs, we treated the MMCs with U73122, an inhibitor that disrupts the catalytic activity of phospholipase C (PLC). Figure 3C and E, this result was also confirmed by using NPS 2390, an antagonist of CaSR (Jung et al., 2005) .
There are numerous reports showing the CaSRs' effect on cell proliferation in many cell types including myeloma (Yamaguchi et al., 2002) , ovarian surface epithelial cells (Hobson et al., 2000) , fibroblasts (McNeil et al., 1998) and osteoblasts (Dvorak et al., 2004) . We also studied the CaSRstimulated mesangial proliferation ( Figure 4A ). Extracellular calcium (5 mM) stimulated the mesangial cell proliferation and this was inhibited by the cotreatment with a CaSR antagonist (NPS 2390, 5 M). The higher concentration of extracellular calcium (10 mM) did not affect cell viability. Thus, the current findings that the CaSR activation evokes a mitogenic effect on the MMCs further support the notion that the CaSR is involved in this physiological process in a variety of cell types. Elevated CaSR expression may contribute to the action of growth signaling pathways, including mitogen-activated protein kinase (McNeil et al., 1998; Yamaguchi et al., 2002) . In addition, many reports have shown that several protein kinases affect the CaSR-induced signaling cascades (Awata et al., 2001; Sakwe et al., 2004) . Therefore, extensive investigations on the relationship between protein kinase and the CaSRs in MMCs will be necessary.
Mesangial cell proliferation is also thought to play an important role in glomerular injury, and mesangial cells may modulate the glomerular filtration rate by altering the surface area and/or the glomerular blood flow (Schlondorff, 1987) . Investigating the role of CaSRs in mesangial cell proliferation is important for understanding the clinical pathophysiology of renal diseases. In conclusion, this study is the first to report that extracellular calcium-induced cytosolic free calcium mobilization in MMCs occurs via the calcium sensing receptor-mediated responses. In addition, the CaSR appears to display mitogenic activity.
